-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
preface
prefaceWhile the COVID-19 epidemic has not yet subsided, the immunization battle of human beings has been hit by monkeypox epidemics
Usa, Canada, Germany, France, Uk, Belgium, Italy, Portugal, Spain, Netherlands, Sweden, Australia, etc
There are no specific therapeutic drugs or vaccines
As of August 25, 2022, data from the U.
There are currently no specific therapeutic drugs or vaccines
The charts are self-made by the author
It is understood that at present, the production capacity of the Danish manufacturing base has reached twice that of before the monkeypox outbreak, and now 30 million doses of Jynneos vaccine can be produced every year, but it still cannot meet the global demand
With the african continent unable to obtain enough vaccines due to tight supply of monkeypox vaccines, there are concerns about the equitable distribution of vaccines
More than 100 million doses of acAM2000 vaccine
Moving from COVID-19 to monkeypox
"Nothing escapes the eyes
According to reports, a number of companies involved in the development of Covid-19 products, such as Vir, the prominent company Moderna and veklury manufacturer Gilead are also involved in the development of
Gilead, a vir company, modelna and veklury manufacturer, also includes NightHawk Biosciences, Blue Water Vaccines and Tonix Pharmaceuticals
Whether there may be differences in patient populations, such as for immunocompromised or infant populations, NightHawk recently revealed that it will once again work with existing partner Lytic Solutions to develop a new monkeypox vaccine
Domestic pharmaceutical companies are clustered to lay out testing reagents
According to reports, a number of domestic enterprises have laid out the monkeypox market
At present, more than 100 domestic pharmaceutical companies have owned and approved the EU CE monkeypox detection box
conclusion
conclusionAt present, although there are no confirmed cases of monkeypox in Chinese mainland, infectious diseases have no borders, and the risk of monkeypox virus importing into China is still there
Monkeypox is more difficult to spread in China, and may be mainly in foreign countries
References: References:
https://endpts.
https://endpts.
Monkeypox is raging, get ready! Which of the 2 vaccines passed by the United States should be given? Where can I play? 》
Other publicly available information
Other publicly available information
